Exceedingly small iron oxide nanoparticles as positive MRI contrast agents. - Wikidata - awgldk - TriplyDB

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

http://www.wikidata.org/entity/Q42318111

about

Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications.Susceptibility weighted imaging and quantitative susceptibility mapping of the cerebral vasculature using ferumoxytol.Nitroxide-Based Macromolecular Contrast Agents with Unprecedented Transverse Relaxivity and Stability for Magnetic Resonance Imaging of Tumors.Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.Stable, small, specific, low-valency quantum dots for single-molecule imaging.Probing the brain with molecular fMRI.Iron Oxide Colloidal Nanoclusters as Theranostic Vehicles and Their Interactions at the Cellular Level.Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics T- and T-weighted Magnetic Resonance Dual Contrast by Single Core Truncated Cubic Iron Oxide Nanoparticles with Abrupt Cellular Internalization and Immune Evasion

P2860

Q36412229-18F3B385-DFF0-43F4-B4B5-4F1905F00EFE Q38668153-172E68A1-3E57-4E1B-8D5F-08D04E17251C Q41162546-CF15D6B7-2879-40FE-84E5-E97B285AF936 Q47409412-EDC2CC83-93D8-4C61-B000-B730412D473E Q49931899-332226C8-6566-448A-8649-F6A0AC161C41 Q52591528-BE60C30A-9DF0-4946-BA9F-02F4334C7118 Q55395357-8A1FCEB9-F27D-48E9-9709-2025D3D0AF5E Q55450179-FB04E3EB-6F32-49EC-9513-C0A16D405D41 Q58291987-8091A154-C3BC-4497-B121-77CD81127785 Q58335465-396F3E78-7EE9-4C02-B132-BE91E7B13C25

P2860

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

http://www.wikidata.org/entity/Q42318111

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@en

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@nl

type

label

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@en

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@nl

prefLabel

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@en

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@nl

P1433

Q42318111-0BA3286B-1289-433D-ACD6-3094D3A11EE1

P1476

Q42318111-F9A870C6-49B7-4838-803C-B658E426E8F2

P2093

Q42318111-1F3036A9-9C34-4B51-978A-757CC76AE0E7

Q42318111-27F9D5B9-C1AF-4FA6-A7DA-AA7C3A25ADAC

Q42318111-32A2274C-A39B-4096-ADC1-0B2C1B87D844

Q42318111-5A0157D8-40E7-4F7A-B7DC-D0B025A461B4

Q42318111-60665DCD-686B-4C0F-881F-4037EEC61ED2

Q42318111-65FD97ED-1BD8-4176-99B8-43E6ABBC0060

Q42318111-788CC371-91E4-4628-B0CB-A860CD5D29E6

Q42318111-7A0B013F-FFCF-47AD-9A5F-BB4CA85B2529

Q42318111-A7B63B9B-1FCD-41EB-A9D3-FF0F1DCEF204

Q42318111-BB69C15C-8C17-4A9C-BBE4-7D5FFE333DEB

P2860

Q42318111-00964D7E-3499-41F2-BE88-D2188EE6387D

Q42318111-08BCB29E-4B50-4CDD-80F8-1595822B3403

Q42318111-12FCB1B3-8C4C-464E-81A7-503867E6A7DE

Q42318111-15C98752-CA40-4D69-8044-C4E084F7531F

Q42318111-160B0FB4-BD22-4BE1-B4F3-DBFD0A73EB4B

Q42318111-17560B64-6245-487F-B14B-751B3B1280AD

Q42318111-1F1EFA52-8E4B-4B0C-82E6-50D2FF1F0C3D

Q42318111-1F8897F9-C6C2-41EE-8364-B0358AC2F85D

Q42318111-28FF58C0-58A1-4844-AD6D-9CE714910066

Q42318111-2F2483B4-4047-4E39-973F-BB1AE7DA1C3A

P304

Q42318111-B1D6927D-3EC9-4858-8B6B-37A7BE6AD035

P31

Q42318111-7B411926-8FCE-46C7-B737-87BE29A293F7

P356

Q42318111-78665112-A62D-462C-BA02-975F2FF14EA4

P407

Q42318111-F421503C-9AD1-4CBB-B420-4155057FEE11

P433

Q42318111-98EA4135-920E-426F-9A93-660AF3ABD6AF

P478

Q42318111-3D86B413-D930-49B6-AD88-6126D926F03C

P50

Q42318111-0D5B1942-2092-4A72-85C9-FFEAFE180B23

Q42318111-AF326B8F-AAFE-41E1-8FEA-5990ADD131E2

Q42318111-C54332CE-4816-40DC-B89A-002784097F58

P577

Q42318111-7764C7C8-F4EF-4147-9B1A-ABE2D3C664E7

P698

Q42318111-EBE71FB2-3738-42A4-97A8-3F15C68D99C4

P921

Q42318111-EC4ED2AD-3325-45CB-84EC-B0248F816BD2

P932

Q42318111-41ADF907-7A05-40C3-AC5D-7377141313AD

P356

PNAS.1620145114

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

@en

P2093

Agata Wiśniowska

http://www.w3.org/2001/XMLSchema#string

Alan Jasanoff

http://www.w3.org/2001/XMLSchema#string

Christian T Farrar

http://www.w3.org/2001/XMLSchema#string

Daniel M Montana

http://www.w3.org/2001/XMLSchema#string

Eric C Hansen

http://www.w3.org/2001/XMLSchema#string

Gerhard Adam

http://www.w3.org/2001/XMLSchema#string

Harald Ittrich

http://www.w3.org/2001/XMLSchema#string

He Wei

http://www.w3.org/2001/XMLSchema#string

Jose M Cordero

http://www.w3.org/2001/XMLSchema#string

Mariya Barch

http://www.w3.org/2001/XMLSchema#string

P2860

Renal clearance of quantum dots.

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging

Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

Compact zwitterion-coated iron oxide nanoparticles for in vitro and in vivo imaging.

High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles.

FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents.

Gadolinium-based hybrid nanoparticles as a positive MR contrast agent.

P304

2325-2330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1620145114

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28193901

http://www.w3.org/2001/XMLSchema#string

P921

P932

5338531

http://www.w3.org/2001/XMLSchema#string